益普索：2023制药行业的全渠道发展现状研究报告
During the pandemic, much effort was devoted to understanding and monitoringhow customer behaviours and preferences evolved. Today, we no longer need togenerate further evidence to support the unique value of in-person interactions orthe need to “go omni”
Instead of simply assessing usage and proclivity across individual channels, thenature of omnichannel engagement demands a more sophisticated understandingof the intricate interactions: channels, channel combinations, content, occasions
and touchpoints.
👇「微信扫描」二维码获取
火石创造：2023年生物医药产业典型发展区域政策分析报告 沙利文：2023医药研发外包服务市场行业研究报告 艾瑞咨询：2023年医药健康行业网络营销监测报告 医药魔方：2022最受全球资本青睐的10大前沿技术 头豹研究院.：2022年中医药高质量发展研究短报告
微信扫码关注该文公众号作者
戳这里提交新闻线索和高质量文章给我们。
来源: qq
点击查看作者最近其他文章